DJIA 16,960.57 -123.23 -0.72%
NASDAQ 4,449.56 -22.54 -0.50%
S&P 500 1,978.34 -9.64 -0.48%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

10.98 -0.03 (-0.27%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $10.98 -0.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.93
Previous Close $11.01
Daily Range $10.81 - $11.05
52-Week Range $8.87 - $15.34
Market Cap $1.4B
P/E Ratio -8.53
Dividend (Yield) $0.00 (0.0%)
Volume 798,331
Average Daily Volume 1,221,535
Current FY EPS -$0.64

Sector

Healthcare

Industry

Drugs

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary

3 Under-the-Radar Biotech Stocks You Need to Watch in 2014

Nektar Therapeutics, Omeros, and Spectrum Pharmaceuticals all face off with regulators in key decision dates for their developmental drugs later this year

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Re

Nektar Therapeutics (NKTR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

AstraZeneca's Naloxegol Data Published - Analyst Blog

Regado Biosciences: The Revolyxis Revolution Has Begun

Nektar Therapeutics (NKTR) in Focus: Stock Rises 10.77% - Tale of the Tape

A Nektar Victory

Relief for Nektar after AADPAC Voting - Analyst Blog

3 Stocks Driving The Drugs Industry Higher

Progenics, Nektar Still Halted; FDA Advisory Committee Expected To Conclude Thursday

Top Healthcare Movers For June 9, 2014

Small Phamaceuticals Rallying Following FDA Report

See More NKTR News...

NKTR's Top Competitors

NKTR $10.98 (-0.27%)
Current stock: NKTR
TMO $125.07 (-0.35%)
Current stock: TMO
ILMN $171.03 (-0.45%)
Current stock: ILMN
WAT $105.96 (0.22%)
Current stock: WAT